Regulation of p27Kip1 by intracellular iron levels

被引:16
|
作者
Wang, G [1 ]
Miskimins, R [1 ]
Miskimins, WK [1 ]
机构
[1] Univ S Dakota, Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA
关键词
D O I
10.1023/A:1024417309370
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enhanced intracellular iron levels are essential for proliferation of mammalian cells. If cells have entered S phase when iron is limiting, an adequate supply of deoxynucleotides cannot be maintained and the cells arrest with incompletely replicated DNA. In contrast, proliferating cells that are not in S phase, but have low iron pools, arrest in late G1. In this report the mechanism of iron-dependent G1 arrest in normal fibroblasts was investigated. Cells were synchronized in G0 by contact inhibition and serum deprivation. Addition of serum caused the cells to re-enter the cell cycle and enter S phase. However, if the cells were also treated with the iron chelator deferoxamine, S phase entry was blocked. This corresponded to elevated levels of the cyclin dependent kinase inhibitor p27(Kip1) and inhibition of CDK2 activity. Expression of other cell cycle regulatory proteins was not affected, including the induction of cyclins D1 and E. When the quiescent serum starved cells were supplemented with a readily usable form of iron in the absence of serum or any other growth factors, a significant population of the cells entered S phase. This was associated with downregulation of p27(Kip1) and increased CDK2 activity. Using an IPTG-responsive construct to artificially raise p27(Kip1) levels blocked the ability of iron supplementation to promote S phase entry. Thus it appears that p27(Kip1) is a mediator of G1 arrest in iron depleted Swiss 3T3 fibroblasts. We propose that this is part of an iron-sensitive checkpoint that functions to ensure that cells have sufficient iron pools to support DNA synthesis prior to entry into S phase.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 50 条
  • [41] Another piece of the p27Kip1 puzzle
    Kaldis, Philipp
    CELL, 2007, 128 (02) : 241 - 244
  • [42] p27Kip1与卵巢肿瘤
    胡春萍
    医学文选, 2003, (06) : 904 - 907
  • [43] Expression and hypermethylation of p27kip1 in hepatocarcinogenesis
    Lei, Pu-Ping
    Zhang, Zong-Ji
    Shen, Li-Juan
    Li, Jin-Yun
    Zou, Qiong
    Zhang, Hua-Xian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (29) : 4587 - 4591
  • [44] Duality of p27Kip1 function in tumorigenesis
    Sicinski, Peter
    Zacharek, Sima
    Kim, Carla
    GENES & DEVELOPMENT, 2007, 21 (14) : 1703 - 1706
  • [45] p27kip1: a target for tumor therapies?
    Irina Nickeleit
    Steffen Zender
    Uta Kossatz
    Nisar P Malek
    Cell Division, 2
  • [46] Eya4 Induces Hypertrophy via Regulation of p27kip1
    Williams, Tatjana
    Hundertmark, Moritz
    Nordbeck, Peter
    Voll, Sabine
    Arias-Loza, Paula Anahi
    Oppelt, Daniel
    Muehlfelder, Melanie
    Schraut, Susanna
    Elsner, Ines
    Czolbe, Martin
    Seidlmayer, Lea
    Heinze, Britta
    Hahner, Stefanie
    Heinze, Katrin
    Schoenberger, Jost
    Jakob, Peter
    Ritter, Oliver
    CIRCULATION-CARDIOVASCULAR GENETICS, 2015, 8 (06) : 752 - 764
  • [47] Eya4 Induces Hypertrophy Via Regulation Of p27kip1
    Williams, Tatjana
    Hundertmark, Moritz
    Nordbeck, Peter
    Voll, Sabine
    Muehlfelder, Melanie
    Schraut, Susanna
    Elsner, Ines
    Schoenberger, Jost
    Ritter, Oliver
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [48] p27Kip1 modulates cell migration through the regulation of RhoA activation
    Besson, A
    Gurian-West, M
    Schmidt, A
    Hall, A
    Roberts, JM
    GENES & DEVELOPMENT, 2004, 18 (08) : 862 - 876
  • [49] The Role of p27Kip1 in the Regulation of Growth Plate Chondrocyte Proliferation in Mice
    Joyce A M Emons
    Rose Marino
    Ola Nilsson
    Kevin M Barnes
    Naomi Even-Zohar
    Anenisia C Andrade
    Neal A Chatterjee
    Jan M Wit
    Marcel Karperien
    Jeffrey Baron
    Pediatric Research, 2006, 60 : 288 - 293
  • [50] Regulation of p27Kip1 expression and subcellular localization by, atypical protein kinase
    Lorimer, IA
    Garratt-Lalonde, M
    Parolin, DA
    Lavictoire, SJ
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6127S - 6127S